What are Peptides and Research Peptides? Definition, Classes, and Quality

What are Peptides? Peptides are short chains of amino acids linked together by so-called peptide bonds. Simply put: they are the small building blocks that make up larger proteins. This article explains the definition of peptides in an easy-to-understand way, clarifies what distinguishes research peptides from approved medicines, and shows how the quality of research material can be objectively recognized.

We treat the subject purely at an educational level. It's about chemistry, classification, and quality features, not about human application, effects, or benefits. If you want to delve deeper into a single research peptide, you will find references to further guides at the end and in the text.

What are Peptides? The Definition Simply Explained

A peptide is a short chain of amino acids. Amino acids are organic molecules that contain an amino group and a carboxyl group. When two amino acids combine, the carboxyl group of one reacts with the amino group of the other. This forms a covalent bond and a water molecule is split off. This reaction is called condensation, and the resulting bond is the peptide bond (an amide bond).^[1]

Because water is lost with each bond, biochemistry no longer refers to whole amino acids in the chain, but to amino acid residues. When many of these residues are linked together, a linear chain with a defined sequence, the amino acid sequence, is formed. This sequence is the fingerprint of every peptide: it determines which molecule it is. Even a single swapped amino acid strictly speaking results in a different peptide with different properties, which explains why the exact sequence is so precisely documented in research.

Peptide Simply Explained: The Short Version

• Building block: Amino acids are the individual units.
• Connection: Peptide bonds (amide bonds) link them into a chain.
• Result: A short, defined amino acid sequence is a peptide.
• Next level: Very long chains fold into proteins.

Peptide vs. Protein: Where is the Line?

The difference between a peptide and a protein is mainly a question of chain length. A generally accepted rule of thumb defines a peptide as a short chain of about 2 to 50 amino acids.^[1] If the chain becomes longer and folds into a three-dimensional structure, it is called a protein. The exact boundary is not set in stone: different sources draw the line between peptide and protein somewhere in the range of about 50 to 100 amino acids.^[2][3]

In addition to pure length, structure is also crucial. A protein folds into a stable, three-dimensional shape that is partly responsible for its biological function. Short peptides, on the other hand, often remain flexible and do not adopt a fixed fold. The transition zone between a long polypeptide and a small protein is therefore fluid, and the numbers mentioned are conventions, not sharp laws of nature.

Mnemonic: Every protein consists of at least one peptide chain, but not every peptide is large enough to be a protein. Peptides are the shorter relatives.

How are Peptides Classified?

Peptides can be classified according to various criteria. Three classifications are particularly common: by chain length, by origin, and by type of biological production.

By Chain Length: Oligopeptides and Polypeptides

Within peptides, a finer distinction is made according to the number of amino acids. The following table assigns common terms to their approximate size ranges, from the shortest peptide to protein as a demarcation:

Term	Approximate Chain Length	Classification
Dipeptide, Tripeptide	2 or 3 amino acids	shortest peptides
Oligopeptide	approx. 4 to 20 amino acids	short chain
Polypeptide	more than approx. 20 amino acids	long, unbranched chain
For comparison: Protein	from approx. 50 amino acids	folded structure, no longer a peptide

The numbers are conventions and not sharp laws of nature. The boundaries between polypeptide and protein overlap, and the 50-amino-acid mark is also just a guideline.^[1][3] The table helps to roughly classify a molecule by its order of magnitude. The last row (Protein) is deliberately added for comparison: a protein is by definition no longer a peptide, but it marks the upper end of the scale.

By Origin: Natural or Synthetic

Peptides can occur naturally in living organisms. Many signaling molecules, hormones, and defense molecules are peptides. In addition, peptides can be produced synthetically, for example, by chemical solid-phase synthesis, in which amino acids are built up step by step into a defined sequence. A synthetically produced peptide can have the same sequence as a natural one but is created in the laboratory and not in a cell. Research peptides belong to this second group.

By Production Method: Ribosomal or Non-Ribosomal

In nature, peptides are formed in two fundamentally different ways. Ribosomal peptides are formed on the ribosome according to the mRNA template, i.e., along the classical genetic code. Non-ribosomal peptides, on the other hand, are assembled by specialized enzyme complexes, the non-ribosomal peptide synthetases. This synthesis takes place independently of the ribosome and occurs primarily in bacteria, fungi, and plants. A well-known example of a non-ribosomally formed peptide is glutathione, a component of the antioxidant defense of many organisms.^[4]

How are Research Peptides Synthesized?

Research peptides are predominantly produced chemically, and the dominant method is solid-phase peptide synthesis (SPPS). The basic principle goes back to Bruce Merrifield, who is considered the founder of solid-phase synthesis. The idea behind it: the growing peptide chain is not built in solution but attached to a solid, insoluble resin. This allows excess reagents and byproducts to be easily washed away after each step without losing the intermediate product.^[8]

Simplified, the synthesis proceeds in recurring cycles:

1. Coupling: The first amino acid is anchored to the resin by its carboxyl group. Its amino group is blocked by a protecting group so that it does not react uncontrollably.
2. Deprotection: The protecting group at the end of the chain is selectively removed so that the next amino acid can dock.
3. Coupling: The next, also protected, amino acid is attached. A new peptide bond is formed.
4. Repetition: Deprotection and coupling are repeated until the desired sequence is complete.
5. Cleavage and purification: Finally, the finished peptide is detached from the resin, freed from the remaining protecting groups, and purified.

Each cycle thus adds exactly one defined amino acid. This explains why purification at the end is so important: even small errors in individual steps can generate truncated or faulty byproducts that must be separated later.^[8] This is exactly where the quality control described later comes into play.

What are Research Peptides?

The term research peptides does not describe a chemical type of its own, but a legal and practical context. Research peptides are synthetically produced research material intended exclusively for laboratory and research purposes. They are not approved medicines and are not intended for human or animal use.

This distinction is important because it defines the legal framework. In Germany, the Medicines Act (AMG) applies. As soon as a substance is demonstrably intended for use on or in humans, it can be classified as a medicine and is then subject to approval. Research material, on the other hand, is treated neutrally as an object of analysis and study, without being intended for use in living beings. Precisely for this reason, clear linguistic rules apply to reputable providers: no indication, no dosage, no instructions for use.

In practice, this means for you as a researcher or buyer: a reputable research peptide comes with technical documentation (sequence, empirical formula, molecular weight, purity), but without promises of healing or effect. Anyone who advertises a peptide with concrete promises for human application leaves the research-only framework. EONA consistently manages its product range as research material and provides batch-related analytics.

What Classes of Research Peptides are There?

Research peptides can be broadly grouped by the field of research in which they are studied. Important upfront: The following points describe exclusively what preclinical research has dealt with. They are not a statement about a benefit, effect, or suitability for humans. The data situation comes predominantly from animal and in vitro models. None of these peptides are approved medicines, and none are intended for human or animal use.

Regeneration-Related Research

This field focuses on peptides that have been studied in preclinical models in connection with tissue regeneration. A frequently cited example is BPC-157, a synthetic, stable pentadecapeptide (15 amino acids). It is computationally derived from a partial sequence of a protein found in gastric juice and is referred to in the literature as a stable gastric pentadecapeptide. In experimental animal models, processes such as angiogenesis and collagen formation have been studied, consistently in vivo and without a robust clinical data basis.^[5]

Another molecule discussed in this field is TB-500, a synthetic fragment derived from the endogenous protein Thymosin Beta-4. In the research literature, the active partial sequence of this protein is described as a starting point for synthetic fragments that have been studied in preclinical models in the context of tissue remodeling. Here too, the data situation is preclinical, and the material is classified purely for research purposes. A detailed, neutral analysis of the study situation on BPC-157 can be found in the BPC-157 Research Hub, and the concrete master data example on the BPC-157 product page.

Growth Hormone Secretagogues (GH Secretagogues)

As secretagogues, research refers to substances that are investigated in experimental models to see if they stimulate the release of an endogenous signaling molecule. Ipamorelin was characterized in preclinical basic research as a selective growth hormone secretagogue, a pentapeptide that has been studied in cell and animal models.^[9] CJC-1295 is a longer, synthetic analog of growth hormone-releasing hormone (GHRH) and also belongs to this experimentally studied class of substances.

Both molecules are frequently mentioned in research in connection with the secretagogue substance class. The classification remains strictly experimental: these are subjects of preclinical investigations, not approved medicines, and not material for human or animal application. Statements about a concrete effect on the organism cannot be derived from the research-only context.

Longevity and Cell Biology-Oriented Research

This group includes peptides that are studied in connection with aging and cell biology. GHK-Cu is a naturally occurring copper tripeptide (Glycyl-L-Histidyl-L-Lysine) first isolated from human plasma in 1973. For decades, it has been the subject of preclinical research on tissue remodeling and gene expression, studied in cell, tissue, and animal models.^[6]

Epitalon (also Epithalon) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly. It was designed based on the amino acid composition of epithalamin, an extract from pineal gland tissue. A review article published in 2025 classifies epitalon as a highly bioactive pineal tetrapeptide and summarizes the preclinical data collected over approximately 25 years, investigated with in vitro, in vivo, and in silico methods in the context of telomere and aging research.^[7] Here too, human data is limited, and the material is classified purely for research purposes.

Cognition-Related Research

Semax is a synthetic heptapeptide described as an analog of the ACTH(4-10) fragment. In preclinical models, Semax was investigated, among other things, in the rat hippocampus in connection with the gene expression of neurotrophic factors and is considered a well-characterized study object in neuropharmacological basic research.^[10] Selank is a synthetic analog of the endogenous peptide tuftsin and is listed as a study molecule in the same research direction. Most of the available data on both peptides come from animal and cell studies; robust clinical evidence in humans remains limited, and it is research material.

Important Distinction: GLP-1 Analogs and HGH are Not Research Peptides

Substances such as Semaglutide, Tirzepatide (GLP-1 or GIP/GLP-1 receptor agonists), or Somatropin/HGH (recombinant growth hormone) are repeatedly mentioned in the same breath. These substances are explicitly not research peptides. They are approved, prescription-only medicines regulated by authorities such as the European Medicines Agency (EMA). Semaglutide, for example, is approved as a medicine (under brand names such as Wegovy or Rybelsus) and is only available on prescription.^[11]

Such medicines belong in medical hands and are not part of the EONA product range. We mention them here solely for clear demarcation: approved, prescription-only medicines on one side, research-only research material on the other. This dividing line is the core of the entire topic.

How to Recognize the Quality of Research Peptides?

Research is only as good as the material it works with. Contaminations or an incorrectly identified substance can distort results and, in the worst case, render an entire series of experiments unusable. Four characteristics help to objectively assess the quality of research peptides.

1. HPLC Purity

The purity of a synthetic peptide is usually determined by reversed-phase HPLC (RP-HPLC), often with UV detection in the range of about 210 to 220 nanometers, because the peptide bond can be well detected there. HPLC separates the components by their hydrophobicity and allows the proportion of impurities to be quantified via the areas of the peaks.^[8] A purity value (for example, a percentage) is only meaningful if it refers to a concrete, documented batch.

2. MS Identity

Purity alone does not yet tell us which molecule is present. This is where mass spectrometry (MS) comes in. It measures the mass-to-charge ratio and confirms the actual molecular weight. The comparison of measured and theoretical mass is the crucial identity test and complements HPLC purity determination. Only both methods together, purity by HPLC and identity by MS, yield a reliable picture.^[8]

3. Batch-Specific COA

A Certificate of Analysis (COA) bundles these test results for a specific batch. A meaningful COA typically states the batch number, manufacturing date, empirical formula, molecular weight, amino acid sequence, and measured versus theoretical mass from MS.^[8] The batch binding is crucial: a general advertising promise of purity without a deposited, batch-specific COA cannot be verified. How to read such a document and what is important is explained step by step in the COA Guide.

4. Origin and Transparency

Traceable origin and independent cross-checking increase reliability. Reputable providers transparently disclose the origin of the material and provide the analytics instead of just claiming them. EONA follows this principle ('verified instead of asserted') and provides batch-related analytics for its research peptides. Which other criteria and warning signs you should check are summarized in the Guide to Recognizing Reputable Peptide Providers.

Why Purity Matters for Reproducible Research

Reproducibility is the foundation of any serious research: a result is only reliable if it can be repeated under the same conditions. This requires that the material used is as consistent as possible in each batch. If the purity varies from batch to batch or if a sample contains unrecognized byproducts, observations can no longer be unequivocally attributed to the substance under investigation. For this reason, batch-related documentation is not a marketing detail but a methodological necessity. A documented purity value, a confirmed identity, and a traceable origin are prerequisites for research results to be comparable and reproducible at all. General quality promises without batch-related proof are not helpful here, because they do not refer to the specifically delivered material.

Frequently Asked Questions (FAQ)

What are peptides simply explained?

Peptides are short chains of amino acids linked together by peptide bonds. They can be thought of as the small building blocks that make up larger proteins. Typically, a peptide consists of about 2 to 50 amino acids.

What is the difference between a peptide and a protein?

The main difference is chain length. Peptides are short chains of amino acids (about 2 to 50 amino acids), while proteins are significantly longer, folded structures. The exact limit is a convention and, depending on the source, is around 50 to 100 amino acids.

What are research peptides?

Research peptides are synthetically produced research material intended exclusively for laboratory and research purposes. They are not an approved drug and are not intended for human or animal use.

Are GLP-1 agents like Semaglutide research peptides?

No. Semaglutide and Tirzepatide are approved, prescription drugs regulated by authorities such as the EMA. They are not research material and are not part of the EONA product range. The same applies to recombinant growth hormone (HGH/Somatropin).

How can you recognize high-quality research peptides?

By four characteristics: HPLC-determined purity, mass spectrometry-confirmed identity, a batch-specific Certificate of Analysis (COA), and traceable origin. Purity specifications are only meaningful if they refer to a specific, documented batch.

Related Articles

• BPC-157: Research Overview – Sequence, preclinical study situation, and quality criteria
• TB-500 and Thymosin Beta-4 – Research overview and quality criteria
• GHK-Cu Copper Peptide – Research overview of the copper tripeptide
• Reading a peptide COA correctly – Understanding HPLC, mass spectrometry, and endotoxin
• Peptide purity and HPLC – how purity is measured and why mass spectrometry is essential
• Third-party lab tests for peptides – why independent testing matters
• Recognizing reputable peptide suppliers – the red flags and what to look for
• Peptides from Europe or China – what matters for origin
• Proper peptide storage – Handling of lyophilized research material

Sources

1. Forbes Kaprive J, Krishnamurthy K. Biochemistry, Peptide. In: StatPearls [Internet]. StatPearls Publishing, updated 2023. NBK562260. ncbi.nlm.nih.gov/books/NBK562260
2. National Human Genome Research Institute (NHGRI). Peptide (Genetics Glossary). genome.gov. genome.gov/genetics-glossary/Peptide
3. Institute for Molecular Bioscience, University of Queensland. Explainer: peptides vs proteins, what's the difference? 2017. imb.uq.edu.au
4. Wikipedia contributors. Peptide. Wikipedia (Overview article, incl. ribosomal vs. non-ribosomal synthesis, glutathione example). en.wikipedia.org/wiki/Peptide
5. Seiwerth S et al. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in Pharmacology, vol. 12, 2021. PMID 34267654. PMC8275860
6. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences, vol. 19(7):1987, 2018. PMID 29986520. PMC6073405
7. Araj SK, Brzezik J, Madra-Gackowska K, Szeleszczuk L. Overview of Epitalon, Highly Bioactive Pineal Tetrapeptide with Promising Properties. International Journal of Molecular Sciences, vol. 26(6):2691, 2025. PMID 40141333. PMC11943447
8. AltaBioscience. Peptide Synthesis, Purification and Product Analysis (Solid-phase synthesis, RP-HPLC at 215 nm, MS identity, COA contents). altabioscience.com
9. Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, vol. 139(5), 552-561, 1998. PMID 9849822. pubmed.ncbi.nlm.nih.gov/9849822
10. Dolotov OV et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Research, vol. 1117(1), 54-60, 2006. PMID 16996037. pubmed.ncbi.nlm.nih.gov/16996037
11. European Medicines Agency (EMA). First oral GLP-1 treatment for weight management (Semaglutide / Wegovy, approved prescription drug). ema.europa.eu

---

Editorial note: This post was created by the EONA editorial team. It is intended solely for general information and education. The mentioned research peptides are research material, intended exclusively for laboratory and research purposes, not an approved drug, and not intended for human or animal use. Mentioned research statements refer to preclinical models (predominantly animal and in-vitro studies) and do not constitute a statement about efficacy, benefit, or suitability in humans.